Persons using assistive technology might not be able to fully access information in this file. For assistance, please send e-mail to: mmwrq@cdc.gov. Type 508 Accommodation and the title of the report in the subject line of e-mail.
On page Q-2, under Figure 1, in footnote 4, Haemophilus
influenzae type b conjugate vaccine (Hib), the
second bullet should read:
TriHiBit® (DTaP/Hib) combination products should not be used for primary immunization but can be used as boosters
after any Hib vaccine in children aged >12
months.
On page Q-4, in the lower section of the Table titled, Catch-up schedule for persons aged 7--18 years, in row
Human Papillomavirus, under column heading Dose 2 to Dose 3, the text should read:
12 weeks (and 24 weeks after the first dose)
Use of trade names and commercial sources is for identification only and does not imply endorsement by the U.S. Department of
Health and Human Services.References to non-CDC sites on the Internet are
provided as a service to MMWR readers and do not constitute or imply
endorsement of these organizations or their programs by CDC or the U.S.
Department of Health and Human Services. CDC is not responsible for the content
of pages found at these sites. URL addresses listed in MMWR were current as of
the date of publication.
Disclaimer
All MMWR HTML versions of articles are electronic conversions from ASCII text
into HTML. This conversion may have resulted in character translation or format errors in the HTML version.
Users should not rely on this HTML document, but are referred to the electronic PDF version and/or
the original MMWR paper copy for the official text, figures, and tables.
An original paper copy of this issue can be obtained from the Superintendent of Documents,
U.S. Government Printing Office (GPO), Washington, DC 20402-9371; telephone: (202) 512-1800.
Contact GPO for current prices.
**Questions or messages regarding errors in formatting should be addressed to
mmwrq@cdc.gov.
